Physical activity has a more beneficial effect on the risk of all-cause mortality in patients with metabolic syndrome than in those without

被引:3
|
作者
Lee, Chang-Hoon [1 ]
Han, Kyung-Do [2 ]
Kwak, Min-Sun [3 ]
机构
[1] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[2] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea
[3] Seoul Natl Univ Hosp, Dept Internal Med, Healthcare Res Inst, Healthcare Syst Gangnam Ctr, 39FL,Gangnam Finance Ctr 737, Seoul 06236, South Korea
关键词
Physical activity; Exercise; Metabolic syndrome; Mortality; SARCOPENIA;
D O I
10.1186/s13098-023-01227-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background It has not been clarified whether physical activity (PA) has more benefit in terms of health outcomes, including mortality risk, among those with metabolic syndrome (MS) compared to those without. Therefore, the aim of this study is to elucidate whether regular PA has interaction with MS on health outcomes.Methods Participants with no underlying cardiovascular diseases who underwent national health screening in 2009 were included. According to the metabolic equivalent (MET)-minutes/week, the amount of PA among the participants was grouped as follows: Group 1 (0 MET-minutes/week), Group 2 (1-499), Group 3 (500-999), Group 4 (1000-1499), and Group 5 (>= 1500). Multivariable Cox proportional hazard models were applied to evaluate the impacts of the amount of PA on health outcomes among those with and without MS. Health outcomes included all-cause mortality and incident cardiovascular diseases (CVDs).Results Of 9,628,109 total participants, 335,970 deaths occurred during a median 8.3-year follow-up. After adjustment for age, sex, smoking status, alcohol consumption, and body mass index, the higher the PA amount was, the lower the risk of all-cause mortality in both those with MS [adjusted hazard ratio (aHR) compared with Group 1, 0.86 (95% CI 0.85, 0.87) in Group 2; 0.82 (95% CI 0.81, 0.83) in Group 3; 0.75 (95% CI 0.74, 0.77) in Group 4; and 0.78 (95% CI 0.76, 0.80) in Group 5; P for trend < 0.001] and those without MS [aHR compared with Group 1, 0.87 (95% CI 0.86, 0.88) in Group 2; 0.84 (95% CI 0.83, 0.85) in Group 3, 0.79 (95% CI 0.78, 0.80) in Group 4, and 0.82 (95% CI 0.81, 0.84) in Group 5; P for trend < 0.001]. The beneficial effects of the amount of PA on all-cause mortality were larger among those with MS than among those without MS in a multiplicative interaction (P for interaction < 0.001). The results were similar in the analysis of the relationship between the PA amount and incident CVD.Conclusions More PA was associated with a lower risk of all-cause mortality, which was more prominent in those with MS than in those without MS. Physicians should emphasize more the importance of PA in patients with MS.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] The Association Between Trajectories of Physical Activity and All-Cause and Cause-Specific Mortality
    Laddu, Deepika
    Parimi, Neeta
    Cauley, Jane A.
    Cawthon, Peggy M.
    Ensrud, Kristine E.
    Orwoll, Eric
    Stefanick, Marcia
    Langsetmo, Lisa
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2018, 73 (12): : 1708 - 1713
  • [22] Changes in physical activity and risk of all-cause mortality in patients on maintence hemodialysis: a retrospective cohort study
    Takahiro Shimoda
    Ryota Matsuzawa
    Kei Yoneki
    Manae Harada
    Takaaki Watanabe
    Mika Matsumoto
    Atsushi Yoshida
    Yasuo Takeuchi
    Atsuhiko Matsunaga
    BMC Nephrology, 18
  • [23] Changes in physical activity and risk of all-cause mortality in patients on maintence hemodialysis: a retrospective cohort study
    Shimoda, Takahiro
    Matsuzawa, Ryota
    Yoneki, Kei
    Harada, Manae
    Watanabe, Takaaki
    Matsumoto, Mika
    Yoshida, Atsushi
    Takeuchi, Yasuo
    Matsunaga, Atsuhiko
    BMC NEPHROLOGY, 2017, 18
  • [24] Long-Term Outcomes Associated with NAFLD, ASCVD, and All-Cause Mortality of Patients with Metabolic Syndrome
    Jitrukthai, Suchanart
    Kositamongkol, Chayanis
    Boonchai, Punyisa
    Mepramoon, Euarat
    Ariyakunaphan, Pinyapat
    Nimitpunya, Pongpol
    Srivanichakorn, Weerachai
    Chaisathaphol, Thanet
    Washirasaksiri, Chaiwat
    Auesomwang, Chonticha
    Sitasuwan, Tullaya
    Tinmanee, Rungsima
    Sayabovorn, Naruemit
    Charatcharoenwitthaya, Phunchai
    Phisalprapa, Pochamana
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [25] Physical Activity-Related Obesity Risk Classification Model and All-Cause Mortality
    Loprinzi, Paul D.
    Addoh, Ovuokerie
    JOURNAL OF PHYSICAL ACTIVITY & HEALTH, 2016, 13 (11) : 1255 - 1262
  • [26] Low Physical Activity and Risk of Cardiovascular and All-Cause Mortality in Renal Transplant Recipients
    Zelle, Dorien M.
    Corpeleijn, Eva
    Stolk, Ronald P.
    de Greef, Mathieu H. G.
    Gans, Rijk O. B.
    van der Heide, Jaap J. Homan
    Navis, Gerjan
    Bakker, Stephan J. L.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (04): : 898 - 905
  • [27] Pacemaker Quantified Physical Activity Predicts All-Cause Mortality
    Tyagi, Sudhi
    Berger, Marcie
    Fox, Judith
    Curley, Michael
    Strath, Scott
    Rubenstein, Jason
    Roth, James
    Widlansky, Michael
    CIRCULATION, 2014, 130
  • [28] Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis
    Nocon, Marc
    Hiemann, Theresa
    Mueller-Riemenschneider, Falk
    Thalau, Frank
    Roll, Stephanie
    Willich, Stefan N.
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2008, 15 (03): : 239 - 246
  • [29] Combined effects of weight loss and physical activity on all-cause mortality of overweight men and women
    Ostergaard, J. N.
    Gronbaek, M.
    Schnohr, P.
    Sorensen, T. I. A.
    Heitmann, B. L.
    INTERNATIONAL JOURNAL OF OBESITY, 2010, 34 (04) : 760 - 769
  • [30] Association between physical activity and all-cause mortality in patients with depression: a prospective cohort study based on NHANES data
    Xiao, Jiaqiang
    Dong, Xiaosheng
    Ding, Meng
    Yang, Qingqing
    Kong, Tao
    FRONTIERS IN PUBLIC HEALTH, 2025, 13